跳至主要内容
临床试验/DRKS00004502
DRKS00004502已完成不适用

on-interventional study to analyse the efectiveness and tolerance of chemotherapy with Docetaxel NC(R) or Doce NC (R) during the treatment of breast cancer and prostate cancer as an application for the daily routine

eocorp GmbH0 个研究点目标入组 450 人开始时间: 2012年12月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Histological backed prostate carcinoma or breast cancer, Age over 18 Years, signed patient informed consent, therapy in a practice, which belongs to BNGO or IQUO.

排除标准

  • Pregnancy, other malignant diseases in the last 5 years, malignant compliance

研究者

发起方
eocorp GmbH

相似试验

on-interventional study to analyse the efectiveness... | 临床试验